Salvage radiation therapy following radical prostatectomy. A national Danish study

Acta Oncologica

Volumn 55, Issue 5, 2016, Pages 598-603

  Ervandian, Maria ^a   Høyer, Morten ^a   Petersen, Stine Elleberg ^a   Sengeløv, Lisa ^b   Hansen, Steinbjørn ^c   Holmberg, Mats ^d   Sveistrup, Joen ^e   Meidahl Petersen, Peter ^e   Borre, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d AALBORG UNIVERSITY HOSPITAL   (Denmark)

^e Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; ANTIANDROGEN;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BIOCHEMICAL RECURRENCE; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; RETROSPECTIVE STUDY; SALVAGE RADIOTHERAPY; SALVAGE THERAPY; ADJUVANT RADIOTHERAPY; BLOOD; DIAGNOSTIC IMAGING; DISEASE FREE SURVIVAL; EPIDEMIOLOGY; PATHOLOGY; PRACTICE GUIDELINE; PROCEDURES; PROGNOSIS; PROSTATE; PROSTATIC NEOPLASMS; SURGICAL MARGIN; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; ANDROGEN ANTAGONISTS; COHORT STUDIES; DENMARK; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; MALE; MARGINS OF EXCISION; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84945207171     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2015.1088170     Document Type: Article

References (25)

1. J.Ferlay, E.Steliarova-Foucher, J.Lortet-Tieulent, S.Rosso, J.W.Coebergh, H.Comber,. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013;49:1374–403.
2. F.J.BiancoJr, P.T.Scardino, J.A.Eastham Radical prostatectomy: Long-term cancer control and recovery of sexual and urinary function (“trifecta”). Urology 2005;66(Suppl 5):83–94.
3. A.J.Stephenson, P.T.Scardino, J.A.Eastham, F.J.BiancoJr, Z.A.Dotan, P.A.Fearn,. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 2006;98:715–17.
4. A.K.Leventis, S.F.Shariat, K.M.Slawin Local recurrence after radical prostatectomy: Correlation of US features with prostatic fossa biopsy findings. Radiology 2001;219:432–9.
5. V.Scattoni, M.Roscigno, M.Raber, F.Montorsi, L.Da Pozzo, G.Guazzoni,. Multiple vesico-urethral biopsies following radical prostatectomy: The predictive roles of TRUS, DRE, PSA and the pathological stage. Eur Urol 2003;44:407–14.
6. M.Picchio, C.Messa, C.Landoni, L.Gianolli, S.Sironi, M.Brioschi,. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: A comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol 2003;169:1337–40.
7. H.D.Pacholke, Z.Wajsman, C.B.Algood, C.G.Morris, R.A.Zlotecki Postoperative adjuvant and salvage radiotherapy for prostate cancer: Impact on freedom from biochemical relapse and survival. Urology 2004;64:982–6.
8. A.J.Stephenson, K.M.Slawin The value of radiotherapy in treating recurrent prostate cancer after radical prostatectomy. Nat Clin Pract Urol 2004;1:90–6.
9. D.Pasquier, C.Ballereau Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: A literature review. Int J Radiat Oncol Biol Phys 2008;72:972–9.
10. M.S.Katz, M.J.Zelefsky, E.S.Venkatraman, Z.Fuks, A.Hummer, S.A.Leibel Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 2003;21:483–9.
11. M.Bolla, H.van Poppel, L.Collette, P.van Cangh, K.Vekemans, L.Da Pozzo,. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 2005;366:572–8.
12. I.M.ThompsonJr, C.M.Tangen, J.Paradelo, M.S.Lucia, G.Miller, D.Troyer,. Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial. JAMA 2006;296:2329–35.
13. T.Wiegel, D.Bottke, U.Steiner, A.Siegmann, R.Golz, S.Störkel,. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 2009;27:2924–30.
14. M.Bolla, H.van Poppel, B.Tombal, K.Vekemans, L.Da Pozzo, T.M.de Reijke,. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 2012;380:2018.
15. C.R.King Adjuvant versus salvage radiotherapy for high-risk prostate cancer patients. Semin Radiat Oncol 2013;23:218–27.
16. R.K.Valicenti, I.ThompsonJr, P.Albertsen, B.J.Davis, S.L.Goldenberg, J.S.Wolf,. Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology/American Urological Association guidelines. Int J Radiat Oncol Biol Phys 2013;86:822–8.
17. J.M.Michalski, C.Lawton, I.El Naqa, M.Ritter, E.O'Meara, M.J.Seider,. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 2010;76:361–8.
18. I.M.Thompson, R.K.Valicenti, P.Albertsen, B.J.Davis, S.L.Goldenberg, C.Hahn,. Adjuvant and salvage radiotherapy after prostatectomy: AUA/ASTRO guideline. J Urol 2013;190:441–9.
19. C.Parker, M.R.Sydes, C.Catton, H.Kynaston, J.Logue, C.Murphy,. Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): A new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy. Br J Urol Int 2007;99:1376–9.
20. P.Martino, V.Scattoni, A.B.Galosi, P.Consonni, C.Trombetta, S.Palazzo,. Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU). World J Urol 2011;29:595–605.
21. H.Vees, F.Buchegger, S.Albrecht, H.Khan, D.Husarik, H.Zaidi, et al. 18F-choline and/or 11C-acetate positron emission tomography: Detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy. Br J Urol Int 2007;99:1415–20.
22. C.Catton, M.Gospodarowicz, P.Warde, T.Panzarella, P.Catton, M.McLean,. Adjuvant and salvage radiation therapy after radical prostatectomy for adenocarcinoma of the prostate. Radiother Oncol 2001;59:51–60.
23. A.J.Stephenson, P.T.Scardino, M.W.Kattan, T.M.Pisansky, K.M.Slawin, E.A.Klein,. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007;25:2035–41.
24. C.R.King, J.C.PrestiJr, H.Gill, J.Brooks, S.L.Hancock Radiotherapy after radical prostatectomy: Does transient androgen suppression improve outcomes? Int J Radiat Oncol Biol Phys 2004;59:341–7.
25. D.E.Soto, M.N.Passarelli, S.Daignault, H.M.Sandler Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patients. Int J Radiat Oncol Biol Phys 2012;82:1227–32.